Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan 13:11:e2.
doi: 10.1017/S1462399409000945.

Inflammation and neuropeptides: the connection in diabetic wound healing

Affiliations
Review

Inflammation and neuropeptides: the connection in diabetic wound healing

Leena Pradhan et al. Expert Rev Mol Med. .

Abstract

Abnormal wound healing is a major complication of both type 1 and type 2 diabetes, with nonhealing foot ulcerations leading in the worst cases to lower-limb amputation. Wound healing requires the integration of complex cellular and molecular events in successive phases of inflammation, cell proliferation, cell migration, angiogenesis and re-epithelialisation. A link between wound healing and the nervous system is clinically apparent as peripheral neuropathy is reported in 30-50% of diabetic patients and is the most common and sensitive predictor of foot ulceration. Indeed, a bidirectional connection between the nervous and the immune systems and its role in wound repair has emerged as one of the focal features of the wound-healing dogma. This review provides a broad overview of the mediators of this connection, which include neuropeptides and cytokines released from nerve fibres, immune cells and cutaneous cells. In-depth understanding of the signalling pathways in the neuroimmune axis in diabetic wound healing is vital to the development of successful wound-healing therapies.

PubMed Disclaimer

Figures

Fig 1
Fig 1. Overview of diabetic wound healing
Diabetes leads to neuropathy, peripheral vascular disease and chronic low grade inflammation, both systemically and peripherally. Neuropathy and chronic low grade inflammation together blunt the acute focused inflammatory response to injury and together with peripheral vascular disease lead to impaired wound healing.
Fig. 2
Fig. 2. Effect of diabetic neuropathy and inflammatory dysregulation on wound healing
Diabetes leads to neuropathy and inflammatory dysregulation which manifests in decreased neuropeptide expression and imbalance in the inflammatory cytokine response. Neuropeptides directly affect leukocytes and monocytes thereby further contributing to the imbalance in cytokine expression. In addition, neuropeptides and cytokines also directly affect endothelial cells and keratinocytes thereby reducing their proliferation and leading to decreased angiogenesis, and re-epithelization. Along with decreased angiogenesis, re-epithelization and dysregulation in the remodeling and extracellular matrix deposition affected by disrupted cytokine expression; the final outcome is abnormal wound healing.

References

    1. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31(3):596–615. - PubMed
    1. Consensus Development Conference on Diabetic Foot Wound Care: 7–8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care. 22(8):1354–1360. - PubMed
    1. Boulton AJ, et al. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–1724. - PubMed
    1. Edmonds ME, et al. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med. 1986;60(232):763–771. - PubMed
    1. Thomson F, et al. A team approach to diabetic foot care--the Manchester experience. The Foot. 1991;1(2):75–82.

Publication types